Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Urology · Peking University Third Hospital · Beijing

Dr. Ma Lulin马潞林

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Ma Lulin

Professional overview

Ma Lulin is a Chief Physician and Professor in the Department of Urology at Peking University Third Hospital, specializing in complex urologic oncology surgery and renal ischemia-reperfusion injury research.

SpecialtyUrology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentDepartment of Urology
HospitalPeking University Third Hospital
CityBeijing
Hospital roleDirector of the Department of Urology

Areas of focus

Renal cell carcinoma with inferior vena cava tumor thrombusSurgical management and comprehensive treatment of renal cell carcinoma with inferior vena cava tumor thrombus
Complex kidney tumorsDiagnosis and treatment of complex kidney tumors, bilateral kidney cancer, and partial nephrectomy
Adrenal tumorsResection of large adrenal tumors
Prostate cancerRadical prostatectomy, including nerve-sparing techniques
Bladder cancerRadical cystectomy with urinary diversion including orthotopic neobladder (Studer), ileal conduit, and cutaneous ureterostomy
Kidney transplantationClinical work in kidney transplantation
Laparoscopic urologic surgeryLaparoscopic radical nephrectomy, partial nephrectomy, radical prostatectomy, and radical cystectomy with lymph node dissection
Renal ischemia-reperfusion injuryMechanistic research on renal ischemia-reperfusion injury and protective interventions

Background

  • 1995Deputy Chief Physician, Department of Urology, Beijing Chaoyang Hospital
  • 2001Professor, Chief Physician, Doctoral Supervisor, and Director of the Department of Urology, Peking University Third Hospital
  • 2010Principal Investigator, National Natural Science Foundation of China (NSFC) Director's Fund (30950018): In vivo study of renal ischemia-reperfusion injury and protective interventions
  • 2014Principal Investigator, Capital Citizens' Health Project Cultivation Fund (Z151100003915105): Clinical multivariate analysis of functional outcomes after laparoscopic radical prostatectomy
  • 2014Principal Investigator, Wu Jieping Medical Foundation: Basic and clinical research on renal ischemia-reperfusion injury
  • 2020Principal Investigator, National Natural Science Foundation of China (NSFC) General Program (81972381): Mechanism of renal cell carcinoma invasion into venous wall in inferior vena cava tumor thrombus

Experience & recognition

  • Recipient of the 2012 Ministry of Education Science and Technology Progress Award (Second Prize)
  • Recipient of the 2013 Chinese Medical Science and Technology Award (Third Prize)
  • Recipient of the 2013 Huaxia Medical Science and Technology Award (Third Prize)
  • Recipient of Beijing Municipal Science and Technology Progress Award (Second Prize and Third Prize)
  • Published over 20 SCI-indexed papers, including in Nature Communications

Professional roles

  • Standing Committee Member, Urological Society, Chinese Medical Association (CMA)
  • Leader, Kidney Transplantation Working Group, Urological Society, Chinese Medical Association (CMA)
  • Leader, Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus Collaboration Group, Urological Society, Chinese Medical Association (CMA)
  • Vice Chair, Urological Society, Beijing Medical Association
  • Deputy Leader, Minimally Invasive Surgery Working Group, Urological Society, Beijing Medical Association
  • Deputy Editor-in-Chief, Chinese Journal of Minimally Invasive Urology
  • Editorial Board Member, Chinese Journal of Urology
  • Communications Editor, Chinese Journal of Surgery

Frequently asked questions

What does Dr. Ma Lulin specialize in?

Specializes in surgical management of renal cell carcinoma with inferior vena cava tumor thrombus, complex kidney tumors, bilateral kidney cancer, large adrenal tumors, radical prostatectomy, radical cystectomy with urinary diversion, kidney transplantation, nerve-sparing techniques, and laparoscopic urologic surgery; also conducts mechanistic research on renal ischemia-reperfusion injury and protective interventions.

Which hospital and department is Dr. Ma Lulin in?

Department of Urology at Peking University Third Hospital

Sources

Dr. Ma Lulin has not reviewed this page. Request a correction or removal.